Cynosure Lutronic

Cynosure, founded in 1991, is a prominent entity operating within the Medical Devices & Equipment and Manufacturing sectors. The company specializes in developing and manufacturing a diverse range of energy-based aesthetic and medical treatment systems. These advanced systems cater to critical applications such as hair removal, skin revitalization, scar reduction, gynecological health, and body contouring. Cynosure's innovative products are utilized worldwide by practitioners, physicians, and aesthetic business owners, enabling them to enhance their service offerings and provide cutting-edge treatments to patients seeking improved health and appearance outcomes.

Operating with a significant scale, Cynosure employs between 1,000-5,000 individuals and maintains a presence across 57 locations, demonstrating a broad operational reach. The company's commitment to innovation and execution is driven by its dedicated workforce, and you can Meet Cynosure's team to learn more about their personnel and leadership driving these advancements. Cynosure's product portfolio includes sophisticated aesthetic technology and medical devices, leveraging energy and laser technologies such as PicoSure, Icon, and SculpSure to deliver effective patient results.

In a competitive landscape featuring key players like Candela, InMode, Cutera, and IPG Photonics, Cynosure generated $350.9M in revenue. Further insights into their financial performance, stability, and investment history are available via Explore financial highlights. The company has secured substantial funding, including a $75 million stock issuance in 2005 and a $60 million private equity round in 2022 from Clayton, Dubilier & Rice, underscoring investor confidence in its strategic direction and market position within the medical aesthetics industry.